Clinical Trials

NCT Number: NCT06064149 Phase: NA Trial Summary: The overarching goal of this trial is to develop mechanisms to improve cardiovascular care among such prostate cancer patients receiving ADT by increasing patient awareness of individualized cardiovas – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Vivek Narayan Acronym:

NCT Number: NCT06074510 Phase: PHASE4 Trial Summary: The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate cancer growing beyond the prostate gland in men wit – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Lantheus Medical Imaging Acronym: […]

NCT Number: NCT06085729 Phase: PHASE1|PHASE2 Trial Summary: To find the best dose of ADI-PEG20 that can be given in combination with carboplatin and cabazitaxel to patients with AVPC. – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): M.D. Anderson Cancer Center Acronym:

NCT Number: NCT06111781 Phase: PHASE2 Trial Summary: The goal of this clinical trial is to measure the toxicity and effectiveness of the following treatments for cFIR/cgUIR prostate cancer patients. Stereotactic body radiotherapy (SBRT) alone or Stereo – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Yale University Acronym:

NCT Number: NCT06193486 Phase: PHASE1 Trial Summary: This is a phase 1 single center clinical trial for patients with end stage Metastatic Castration Resistant Prostate Cancer who have progressed through standard of care treatment options and are on zol – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): H. Lee Moffitt Cancer Center and […]

NCT Number: NCT06237179 Phase: PHASE1|PHASE2 Trial Summary: To test the preliminary effectiveness of a home-based exercise training (ET) intervention to improve exercise capacity (VO2 peak & 6-minute walk distance [6MWD]) among prostate cancer (PC) patients – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Virginia Commonwealth University Acronym: EXTRA-PC

NCT Number: NCT06238479 Phase: PHASE1 Trial Summary: The purpose of this study is to find out whether the study drug, LY4101174, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors. The study is conducted in two pa – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Eli Lilly and Company […]

NCT Number: NCT06242470 Phase: PHASE1 Trial Summary: The study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants with relapsed or refractory, unresectable, – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): MacroGenics Acronym:

NCT Number: NCT05948657 Phase: Trial Summary: This study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (AS) with low risk and favorable intermedi – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Weill Medical College of Cornell University Acronym: ESCAPE

NCT Number: NCT06244004 Phase: PHASE2 Trial Summary: This phase II trial compares the effect of FDG-positron emission tomography (PET)-guided metastasis directed radiation therapy (MDRT) in combination with standard treatments to standard treatments alo – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Northwestern University Acronym: